Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives.
Study Design
- 연구 유형
- Review
- 중재
- Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives. Low-level laser/light therapy (various devices and dosimetry)
- 대조군
- Placebo
- 효과 방향
- Positive
- 비뚤림 위험
- Unclear
Abstract
Photobiomodulation (PBM) or low-level laser therapy was discovered over 50 years ago, when Mester in Hungary observed regrowth of hair in mice when irradiated with a ruby laser. At the present time, several different PBM devices are marketed to assist with hair regrowth in alopecia patients. This review covers the three main types of alopecia (androgenetic, areata, and chemotherapy-induced), and discusses the mechanism of action of PBM for each disease. The different devices used (mostly low powered red laser diodes), dosimetry, animal models, and clinical trials are summarized. Criteria for patient selection are outlined. Finally a perspectives section looks forward to the future.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Lasers in surgery and medicine · 2014
Low-level laser (light) therapy (LLLT) for treatment of hair loss.
American journal of clinical dermatology · 2014
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.
Expert opinion on pharmacotherapy · 2020
A review of the treatment of male pattern hair loss.
Lasers in surgery and medicine · 2013
The growth of human scalp hair mediated by visible red light laser and LED sources in males.
Dermatologic therapy · 2019